Therapeutic Advances in Cardiovascular Disease
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.3 | Q2 | 66.2% | 0.862 | Q2 | 79.7% |
| 2024 | 2.2 | Q2 | 52.2% | 0.602 | Q2 | 68.5% |
| 2023 | 2.6 | Q2 | 65.6% | 0.553 | Q2 | 68.2% |
| 2022 | 2.3 | 55.0% | 0.784 | Q2 | 79.9% | |
| 2021 | — | 39.6% | 0.816 | Q2 | 81.7% | |
| 2020 | — | — | 1.164 | Q1 | 88.4% | |
| 2019 | — | — | 0.599 | Q2 | 72.6% | |
| 2018 | — | — | 0.537 | Q3 | 67.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1753-9447
ISSN
1753-9455
country
GBcoverage
2007-2026